Vice President of Preclinical DevelopmentIonis PharmaceuticalsCarlsbad, California, United States
Hitching a Ride to Transduce Barriers: Nonclinical Safety Considerations for Developing Transcriptome Modulating Therapies (S08)
Tuesday, November 19, 20249:00 AM – 12:00 PM CT
Adapting Nonclinical Strategies to Accommodate Evolution of Antisense Oligonucleotide Technologies (S08-3)
Tuesday, November 19, 20249:40 AM – 10:15 AM CT